LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA group (Alternext Paris:FR0004178572 – ALMED,PEA-PME eligible), which specializes in the development and manufacturing of innovative surgical technologies for the treatment of spinal pathologies, announces its results for its 1st half to June 30th, 2015